VOYA Investment Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-210,074
Closed -$9.76M 2960
2023
Q2
$9.76M Buy
210,074
+127,166
+153% +$4.4M 0.01% 745
2023
Q1
$2.38M Buy
82,908
+53,615
+183% +$1.59M ﹤0.01% 1285
2022
Q4
$914K Buy
29,293
+18,074
+161% +$589K ﹤0.01% 1683
2022
Q3
$228K Buy
11,219
+652
+6% +$11.9K ﹤0.01% 2524
2022
Q2
$164K Buy
+10,567
New +$182K ﹤0.01% 2471

VOYA Investment Management's DICE Position: Q3 2023 in Review

VOYA Investment Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 210,074 shares — an estimated $9.76M sold.

VOYA Investment Management first reported a position in DICE in Q2 2022 and held it in 5 quarters. The position peaked at $9.76M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • VOYA Investment Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • VOYA Investment Management sold 210,074 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.76M.
  • VOYA Investment Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • VOYA Investment Management's DICE Therapeutics, Inc. Common Stock position peaked at $9.76M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on VOYA Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.